Non-Invasive At-Home Sleep Therapy System

Description

The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in healthy adults via home use sleep therapy device (SleepWISP). Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep. The clinical trial aims to answer the following main questions: 1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could improve sleep quality.

Conditions

Sleep, Sleep Duration, Sleep Quality

Study Overview

Study Details

Study overview

The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in healthy adults via home use sleep therapy device (SleepWISP). Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep. The clinical trial aims to answer the following main questions: 1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could improve sleep quality.

Non-Invasive At-Home Sleep Therapy System

Non-Invasive At-Home Sleep Therapy System

Condition
Sleep
Intervention / Treatment

-

Contacts and Locations

Eugene

Brain Electrophysiology Laboratory Company, Eugene, Oregon, United States, 97403

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Normally aging adults between the ages of 22-85
  • * History of seizures
  • * History of epilepsy
  • * History of brain injury or trauma (including neurosurgery)
  • * History or presence of significant neurological disease such as Parkinson
  • * History of Electroconvulsive Therapy (ECT)
  • * Presence of severe insomnia
  • * Presence of sleep apnea
  • * Presence of severe anxiety or depression
  • * Taking medications that may affect the EEG
  • * History of stroke
  • * Sensitivity or allergy to lidocaine or silver
  • * Presence of active suicidal ideation
  • * Presence of metal in head or implants or medication infusion device
  • * Pregnancy
  • * Adverse reaction to TMS

Ages Eligible for Study

22 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Brain Electrophysiology Laboratory Company,

Study Record Dates

2023-10-31